GLENMEDE TRUST CO NA - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 102 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q1 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q4 2015$1,000
-50.0%
163
-42.2%
0.00%
Q3 2015$2,000
-84.6%
2820.0%0.00%
Q2 2015$13,000
+30.0%
2820.0%0.00%
Q1 2015$10,000
-23.1%
282
-17.8%
0.00%
Q4 2014$13,000
+116.7%
3430.0%0.00%
Q3 2014$6,000
+500.0%
343
+345.5%
0.00%
Q2 2014$1,000
-50.0%
77
-61.1%
0.00%
Q1 2014$2,0001980.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q1 2016
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders